CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus
Cancers, vol. 13, pp. 1050
Abstract
Spacer or co-stimulatory components in chimeric antigen receptor (CAR) design influence CAR T cell effector function. Few preclinical mouse models optimally support CAR candidate pre-selection for clinical development. Here we use a model in which murine CAR T cells can be exploited with human tumor xenografts. This mouse-in-mouse approach avoids limitations caused by species-specific factors crucial for CAR T cell survival, trafficking and function. We compared trafficking, expansion and tumor control for T cells expressing different CAR construct designs targeting two antigens (L1CAM or HER2), structurally identical except for spacer (long or short) or co-stimulatory (4-1BB or CD28) domains to be evaluated. Using monoclonal, murine-derived L1CAM-specific CAR T cells in Rag-/- mice harboring established xenografted tumors from a human neuroblastoma cell line revealed a clear superiority in CAR T cell trafficking using CD28 co-stimulation. L1CAM-targeting short spacer-CD28/ζ CAR T cells expanded the most at the tumor site and induced initial tumor regression. Treating patient-derived neuroblastoma xenografts with human L1CAM-targeting CAR T cells confirmed the superiority of CD28 co-stimulus. CD28 superiority was also demonstrated with HER2-specific CAR T cells (targeting ovarian carcinoma xenografts). Our findings encourage incorporating CD28 signaling into CAR design for adoptive T cell treatment of solid tumors.
Authors 15
-
Max Delbrück Center · Leiden University Medical Center · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
Institute of Immunology, Charité Campus Buch, 13092 Berlin, Germany
Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13092 Berlin, Germany
-
Humboldt-Universität zu Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
-
Humboldt-Universität zu Berlin · Deutsches Konsortium für Translationale Krebsforschung · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), 10178 Berlin, Germany
-
Humboldt-Universität zu Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
-
Humboldt-Universität zu Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
-
Humboldt-Universität zu Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
-
Affiliation as printed
Experimental Pharmacology & Oncology Berlin Buch, 13125 Berlin, Germany
-
Affiliation as printed
Experimental Pharmacology & Oncology Berlin Buch, 13125 Berlin, Germany
-
Humboldt-Universität zu Berlin · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Berlin Institute of Health (BIH), 10178 Berlin, Germany
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
Experimental and Clinical Research Center, Lindenberger Weg 80, 13125 Berlin, Germany
-
Affiliation as printed
Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13092 Berlin, Germany
-
German Cancer Research Center · Humboldt-Universität zu Berlin · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Deutsches Konsortium für Translationale Krebsforschung · Charité - Universitätsmedizin Berlin
Affiliation as printed
Berlin Institute of Health (BIH), 10178 Berlin, Germany
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), 10178 Berlin, Germany
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
-
German Cancer Research Center · Humboldt-Universität zu Berlin · Deutsches Konsortium für Translationale Krebsforschung · Charité - Universitätsmedizin Berlin
Affiliation as printed
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), 10178 Berlin, Germany
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
-
University of Washington · Fred Hutch Cancer Center · Seattle Children's Research Institute
Affiliation as printed
Department of Bioengineering, University of Washington, Seattle, WA 98195, USA
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Seattle Children’s Therapeutics, Seattle Children’s Research Institute, Seattle, WA 98101, USA
Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA 98101, USA
-
Max Delbrück Center · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Charité - Universitätsmedizin Berlin
Affiliation as printed
Institute of Immunology, Charité Campus Buch, 13092 Berlin, Germany
Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13092 Berlin, Germany
-
Annette Künkele corresponding
German Cancer Research Center · Humboldt-Universität zu Berlin · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Deutsches Konsortium für Translationale Krebsforschung · Charité - Universitätsmedizin Berlin
Affiliation as printed
Berlin Institute of Health (BIH), 10178 Berlin, Germany
Department of Pediatric Oncology and Hematology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), 10178 Berlin, Germany
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Cited by 46 stored of 47
Cited by patents worldwide 3 (Lens.org)
-
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptorsUS12629430B2 2026-05-19 Active
-
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptorsUS12564648B2 2026-03-03 Active
-
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptorsUS12350349B2 2025-07-08 Active